<DOC>
	<DOCNO>NCT02445755</DOCNO>
	<brief_summary>The purpose study test performance new transcutaneous ( `` measure skin '' ) bilirubin device ( BiliCare™ ) measure bilirubin level . The investigator plan evaluate clinical performance device point care test . If investigator validate BiliCare™ bilirubin baby 's blood could verify non-invasive alternative measuring bilirubin .</brief_summary>
	<brief_title>Transcutaneous Bilirubinometry Neonates With Bilicare System</brief_title>
	<detailed_description />
	<criteria>1 . Parental inform consent 2 . Male female newborn GA ≥ 35 wks 3 . Enrollment age &gt; 6 hr neonatal discharge 4 . Prephototherapy 1 . Infants require respiratory assistance ( mechanical ventilation ) 2 . Severe lifethreatening congenital anomaly 3 . Hematomas point measurement ears 4 . Neonates undergone blood transfusion</criteria>
	<gender>All</gender>
	<minimum_age>35 Weeks</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Neonates</keyword>
	<keyword>Bilicare System</keyword>
</DOC>